{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T15:10:25Z","timestamp":1710429025561},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/ede.0b013e3181a66457","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T11:10:09Z","timestamp":1244805009000},"page":"584-589","source":"Crossref","is-referenced-by-count":4,"title":["Fetal Down Syndrome and the Risk of Maternal Breast Cancer"],"prefix":"10.1097","volume":"20","author":[{"given":"Tone","family":"Bj\u00f8rge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Cnattingius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steinar","family":"Tretli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolv Terje","family":"Lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annekatrin","family":"Lukanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210207","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer.","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"R2-18-20210207","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.96.5.2520","article-title":"Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.","volume":"96","author":"Guzman","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-18-20210207","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1677\/erc.1.00804","article-title":"Mammary developmental fate and breast cancer risk.","volume":"12","author":"Medina","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R4-18-20210207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1018770218022","article-title":"Role of hormones in mammary cancer initiation and progression.","volume":"3","author":"Russo","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R5-18-20210207","first-page":"259","article-title":"Clinical Gynecologic Endocrinology and Infertility.","year":"2005"},{"key":"R6-18-20210207","first-page":"437","article-title":"Treatment with human chorionic gonadotropin and risk of breast cancer.","volume":"4","author":"Bernstein","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-18-20210207","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/01.AOG.0000241095.19638.f2","article-title":"Comparison of serum markers in first-trimester down syndrome screening.","volume":"108","author":"Canick","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R8-18-20210207","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta2010","article-title":"Antenatal screening for Down's syndrome.","volume":"2","author":"Wald","year":"1998","journal-title":"Health Technol Assess"},{"key":"R9-18-20210207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/000456320203900604","article-title":"Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy.","volume":"39","author":"Spencer","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"R10-18-20210207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.1970110102","article-title":"Trisomic pregnancies have normal human chorionic gonadotropin bioactivity.","volume":"11","author":"Kratzer","year":"1991","journal-title":"Prenat Diagn"},{"key":"R11-18-20210207","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/1055-9965.EPI-07-2630","article-title":"Cancer risk in children with birth defects and in their families. A population based cohort study of 5.2 million children from Norway and Sweden.","volume":"17","author":"Bj\u00f8rge","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-18-20210207","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0412.2000.079006435.x","article-title":"The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years.","volume":"79","author":"Irgens","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R17-18-20210207","first-page":"1","article-title":"Analysis of Survival Data.","author":"Cox","year":"1984"},{"key":"R19-18-20210207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6602302","article-title":"Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects.","volume":"92","author":"Albrektsen","year":"2005","journal-title":"Br J Cancer"},{"key":"R20-18-20210207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199407073310102","article-title":"Transient increase in the risk of breast cancer after giving birth.","volume":"331","author":"Lambe","year":"1994","journal-title":"N Engl J Med"},{"key":"R21-18-20210207","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1015287208222","article-title":"Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden).","volume":"13","author":"Liu","year":"2002","journal-title":"Cancer Causes Control"},{"key":"R22-18-20210207","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.bjc.6600124","article-title":"Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women.","volume":"86","author":"Clavel-Chapelon","year":"2002","journal-title":"Br J Cancer"},{"key":"R23-18-20210207","first-page":"1333","article-title":"The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum.","volume":"75","author":"Goodwin","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-18-20210207","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1471-0528.1985.tb01084.x","article-title":"Serum chorionic gonadotrophin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy.","volume":"92","author":"Masson","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"R25-18-20210207","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008915217389","article-title":"Hydatidiform moles and the long-term risk of breast cancer (Sweden).","volume":"11","author":"Erlandsson","year":"2000","journal-title":"Cancer Causes Control"},{"key":"R26-18-20210207","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/bjc.1997.346","article-title":"Breastfeeding history, pregnancy experience and risk of breast cancer.","volume":"76","author":"Enger","year":"1997","journal-title":"Br J Cancer"},{"key":"R27-18-20210207","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.bjc.6600605","article-title":"Hyperemesis gravidarum and subsequent breast cancer risk.","volume":"87","author":"Erlandsson","year":"2002","journal-title":"Br J Cancer"},{"key":"R28-18-20210207","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001648-199811000-00014","article-title":"Pregnancy characteristics and maternal risk of breast cancer.","volume":"9","author":"Troisi","year":"1998","journal-title":"Epidemiology"},{"key":"R29-18-20210207","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9378(97)70512-X","article-title":"The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia.","volume":"176","author":"Ashour","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R30-18-20210207","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000081369","article-title":"Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.","volume":"20","author":"Audibert","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"R31-18-20210207","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1071-5576(00)00050-2","article-title":"Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin A as predictors of preeclampsia in the third trimester of pregnancy.","volume":"7","author":"Lambert-Messerlian","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"R32-18-20210207","first-page":"314","article-title":"Characteristics of first pregnancy in relation to early breast cancer. A case-control study.","volume":"28","author":"Polednak","year":"1983","journal-title":"J Reprod Med"},{"key":"R33-18-20210207","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/aje\/kwk105","article-title":"Preeclampsia, pregnancy-related hypertension, and breast cancer risk.","volume":"165","author":"Terry","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R34-18-20210207","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.bjc.6600581","article-title":"Pre-eclampsia in pregnancy and subsequent risk for breast cancer.","volume":"87","author":"Vatten","year":"2002","journal-title":"Br J Cancer"},{"key":"R35-18-20210207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(02)00186-9","article-title":"Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.","volume":"323","author":"Benn","year":"2002","journal-title":"Clin Chim Acta"},{"key":"R36-18-20210207","first-page":"361","article-title":"Steroid hormone levels during pregnancy and incidence of maternal breast cancer.","volume":"11","author":"Peck","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R37-18-20210207","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jnci\/92.12.1001","article-title":"Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.","volume":"92","author":"Melbye","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R38-18-20210207","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/oxfordjournals.aje.a009691","article-title":"Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.","volume":"148","author":"Richardson","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R39-18-20210207","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1651-2227.2003.tb00835.x","article-title":"Down syndrome and breastfeeding.","volume":"92","author":"Pisacane","year":"2003","journal-title":"Acta Paediatr"},{"key":"R40-18-20210207","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.440","article-title":"Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.","volume":"22","author":"Rudnicka","year":"2002","journal-title":"Prenat Diagn"},{"key":"R41-18-20210207","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ijc.20532","article-title":"Down's syndrome protects against breast cancer: is a constitutional cell microenvironment the key?","volume":"113","author":"Benard","year":"2005","journal-title":"Int J Cancer"},{"key":"R42-18-20210207","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome.","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"R43-18-20210207","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","article-title":"Pattern of malignant disorders in individuals with Down's syndrome.","volume":"2","author":"Hasle","year":"2001","journal-title":"Lancet Oncol"},{"key":"R44-18-20210207","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.163.6.705","article-title":"Mortality and cancer incidence among individuals with Down syndrome.","volume":"163","author":"Hill","year":"2003","journal-title":"Arch Intern Med"},{"key":"R45-18-20210207","first-page":"628","article-title":"Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study.","volume":"58","author":"Yoon","year":"1996","journal-title":"Am J Hum Genet"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0b013e3181a66457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T14:56:20Z","timestamp":1710428180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001648-200907000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0b013e3181a66457","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}